Christine Mikail Cvijic, President and CFO of Neurogene Inc. ($NGNE), sold shares once on the open market in the last 365 days for a total of $120,526. Her most recent sale occurred on February 27, 2026. These sales rank 9,304th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | S | Common Stock | 2558 | $21.62 | 103,240.0000 | 21,168,431 | 2.42% | 0.01% |
| March 13, 2026 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | S | Common Stock | 2387 | $20.42 | 107,456.0000 | 21,168,431 | 2.17% | 0.01% |
| March 13, 2026 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | S | Common Stock | 1395 | $21.25 | 106,061.0000 | 21,168,431 | 1.30% | 0.01% |
| March 13, 2026 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | S | Common Stock | 263 | $22.02 | 105,798.0000 | 21,168,431 | 0.25% | 0.00% |
| Feb. 27, 2026 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | S | Common Stock | 4800 | $25.11 | 109,843.0000 | 21,168,431 | 4.19% | 0.02% |
| Feb. 20, 2026 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | A | Stock Option (Right to Buy) | 131900 | $0.00 | 131,900.0000 | 21,168,431 | 9999.99% | 0.62% |
| Feb. 20, 2026 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | A | Common Stock | 22000 | $0.00 | 114,643.0000 | 21,168,431 | 23.75% | 0.10% |
| March 26, 2025 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | A | Common Stock | 20300 | $0.00 | 92,643.0000 | 17,567,082 | 28.06% | 0.12% |
| March 26, 2025 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | A | Employee Stock Option (Right to buy) | 122000 | $0.00 | 122,000.0000 | 17,567,082 | 9999.99% | 0.69% |
| March 13, 2025 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | S | Common Stock | 4501 | $16.94 | 72,343.0000 | 17,567,082 | 5.86% | 0.03% |
| Nov. 22, 2024 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | P | Common Stock | 24000 | $20.48 | 76,844.0000 | 16,953,443 | 45.42% | 0.14% |
| March 13, 2024 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | A | Employee Stock Option (Right to buy) | 53900 | $0.00 | 53,900.0000 | 4,656,947 | 9999.99% | 1.16% |
| March 13, 2024 | Neurogene Inc. | $NGNE | Cvijic Christine Mikail | President and CFO | A | Common Stock | 31903 | $0.00 | 52,844.0000 | 4,656,947 | 152.35% | 0.69% |